MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/emermed-2023-213772

Медицинская библиотека · Emergency medicine journal : EMJ · 2024

Diagnostic accuracy of alternative biomarkers for acute aortic syndrome: a systematic review.

Wren Joshua, Goodacre Steve, Pandor Abdullah, Essat Munira, Clowes Mark, Cooper Graham, Hinchliffe Robert, Reed Matthew J, Thomas Steven, Wilson Sarah

Систематический обзорСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

D-dimer is the only biomarker currently recommended in guidelines for the diagnosis of acute aortic syndrome (AAS). We undertook a systematic review to determine whether any alternative biomarkers could be useful in AAS diagnosis.

METHODS

We searched electronic databases (including MEDLINE, EMBASE and the Cochrane Library) from inception to February 2024. Diagnostic studies were eligible if they examined biomarkers other than D-dimer for diagnosing AAS compared with a reference standard test in people presenting to the ED with symptoms of AAS. Case-control studies were identified but excluded due to high risk of bias. Selection of studies, data extraction and risk of bias assessments using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool were undertaken independently by at least two reviewers. We used narrative synthesis to summarise the findings.

RESULTS

We identified 2017 citations, included 13 cohort studies (n=76-999), and excluded 38 case-control studies. Methodological quality was variable, with most included studies having unclear or high risk of bias and applicability concerns in at least one item of the QUADAS-2 tool. Only two studies reported biomarkers with sensitivity and specificity comparable to D-dimer (ie, >90% and >50%, respectively). Wang et al reported 99.1% sensitivity and 84.9% specificity for soluble ST2; however, these findings conflicted with estimates of 58% sensitivity and 70.8% specificity reported in another study. Chun and Siu reported 95.6% sensitivity and 56.1% specificity for neutrophil count, but this has not been confirmed elsewhere.

CONCLUSION

There are many potential alternative biomarkers for AAS but few have been evaluated in more than one study, study designs are often weak and reported biomarker accuracy is modest or inconsistent between studies. Alternative biomarkers to D-dimer are not ready for routine clinical use.

PROSPERO REGISTRATION NUMBER: CRD42022252121.

Для цитирования: Wren Joshua, Goodacre Steve, Pandor Abdullah, Essat Munira, Clowes Mark, Cooper Graham, Hinchliffe Robert, Reed Matthew J, Thomas Steven, Wilson Sarah. Diagnostic accuracy of alternative biomarkers for acute aortic syndrome: a systematic review.. Emergency medicine journal : EMJ. 2024. DOI: 10.1136/emermed-2023-213772.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.